Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acamprosate Pretreatment for Alcohol Withdrawal
NCT00004552Phase 2Completed
- Sponsor
- Yale University
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acamprosate in alcohol withdrawal syndrome (AWS), sponsored by Yale University. Status: completed.
02
Drugs
acamprosate
03
Conditions
alcohol withdrawal syndrome (AWS)
Beyond the preview
Go deeper on NCT00004552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004552.